Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial
Overview[ - collapse ][ - ]
Purpose | The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone. |
---|---|
Condition | Cervical Strain |
Intervention | Drug: Cyclobenzaprine Drug: Ibuprofen Drug: Ibuprofen plus Cyclobenzaprine |
Phase | Phase 2 |
Sponsor | Stony Brook University |
Responsible Party | Stony Brook University |
ClinicalTrials.gov Identifier | NCT00790270 |
First Received | November 12, 2008 |
Last Updated | October 22, 2012 |
Last verified | October 2012 |
Tracking Information[ + expand ][ + ]
First Received Date | November 12, 2008 |
---|---|
Last Updated Date | October 22, 2012 |
Start Date | January 2003 |
Estimated Primary Completion Date | January 2004 |
Current Primary Outcome Measures |
|
Current Secondary Outcome Measures |
|
Descriptive Information[ + expand ][ + ]
Brief Title | Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial |
---|---|
Official Title | Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial |
Brief Summary | The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone. |
Detailed Description | Muscle relaxants have been used extensively for neck and back pain since muscle spasm is thought to play a role in the cycle of pain and spasm. However, prior studies have conflicting results regarding their additive effect when given in addition to analgesics such as the NSAIDs. Because they have the potential to lead to adverse events their efficacy should be clearly demonstrated before their routine use. |
Study Type | Interventional |
Study Phase | Phase 2 |
Study Design | Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment |
Condition | Cervical Strain |
Intervention | Drug: Cyclobenzaprine 5 mg orally every 8 hours as needed Other Names: flexerilDrug: Ibuprofen Ibuprofen 400 mg every 8 hours as needed Other Names: motrin, advilDrug: Ibuprofen plus Cyclobenzaprine Ibuprofen 400 mg plus cyclobenzaprine 5 mg every 8 hours as needed Other Names: motrin or advil with flexeril |
Study Arm (s) |
|
Recruitment Information[ + expand ][ + ]
Recruitment Status | Completed |
---|---|
Estimated Enrollment | 61 |
Estimated Completion Date | January 2004 |
Estimated Primary Completion Date | January 2004 |
Eligibility Criteria | Inclusion Criteria: - neck pain within 24 hours of injury Exclusion Criteria: - Children, allergy or contraindication to any of the study drugs |
Gender | Both |
Ages | 18 Years |
Accepts Healthy Volunteers | No |
Contacts | Not Provided |
Location Countries | United States |
Administrative Information[ + expand ][ + ]
NCT Number | NCT00790270 |
---|---|
Other Study ID Numbers | SB2003-1234 |
Has Data Monitoring Committee | No |
Information Provided By | Stony Brook University |
Study Sponsor | Stony Brook University |
Collaborators | Not Provided |
Investigators | Principal Investigator: adam singer, md Stony Brook University |
Verification Date | October 2012 |
Locations[ + expand ][ + ]
Stony Brook University | Stony Brook, New York, United States, 11733 |
---|